Prevention of Anthracyclines and HER2 Inhibitor-Induced Cardiotoxicity: A Systematic Review and Meta-Analysis

This meta-analysis and systematic review aim to consolidate evidence on cardiotoxicity prevention and treatment strategies in patients receiving anthracyclines or HER2 receptor inhibitors, vital treatments for breast cancer and hematologic malignancies. By synthesizing existing research, the goal is...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancers 2024-06, Vol.16 (13), p.2419
Hauptverfasser:	Sotiropoulou, Ioanna Myrto, Manetas-Stavrakakis, Nikolaos, Kourek, Christos, Xanthopoulos, Andrew, Magouliotis, Dimitrios, Giamouzis, Grigorios, Skoularigis, John, Briasoulis, Alexandros
Format:	Artikel
Sprache:	eng
Schlagworte:	Angiotensin Angiotensin-converting enzyme inhibitors Anthracycline Beta blockers Biomarkers Breast cancer Cancer therapies Cardiotoxicity Cardiovascular disease Cardiovascular diseases Chemotherapy Clinical trials Disease prevention Ejection fraction ErbB-2 protein Heart Heart failure Hematology Leukemia Malignancy Meta-analysis Oxidative stress Patients Pediatrics Peptidyl-dipeptidase A Razoxane Systematic review Toxicity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!